Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
57,178,368
-
Share change
-
+4,343,718
-
Total reported value
-
$10,156,395,395
-
Put/Call ratio
-
84%
-
Price per share
-
$177.64
-
Number of holders
-
481
-
Value change
-
+$780,868,772
-
Number of buys
-
297
-
Number of sells
-
169
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2021
As of 30 Jun 2021,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
481 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,178,368 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, LSV ASSET MANAGEMENT, WELLINGTON MANAGEMENT GROUP LLP, Polaris Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
482
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.